Navigation Links
Childhood cancer survivors at increased risk of certain tumors in middle-age
Date:6/4/2011

In a study that included nearly 18,000 children who had cancer, with follow-up of about 25 years, the greatest excess risk associated with a subsequent primary neoplasm (a new tumor) at older than age 40 years was for digestive and genitourinary neoplasms (related to the genital or urinary tract organs), according to a study in the June 8 issue of JAMA, a theme issue on cancer. The study is being published early online to coincide with the American Society of Clinical Oncology 2011 Annual Meeting.

"Survivors of childhood cancer are at increased risk of developing subsequent primary neoplasms with the risk being estimated at 3- to 6-fold than expected. However, the magnitude of the long-term risks of developing a subsequent primary neoplasm, in particular beyond ages at which the background cancer incidence in the general population starts to increase substantially, are unknown," according to background information in the article. "It is essential to investigate the long-term risks of subsequent primary neoplasms since any increased relative risk (RR) sustained into old age would lead to a substantial number of survivors being diagnosed with a subsequent primary neoplasm. To reduce the number of subsequent primary neoplasms, prevention, screening, and other intervention strategies should focus on subsequent primary neoplasm types with the highest absolute excess risks (AERs); however, it is currently unclear which subsequent primary neoplasm types contribute most to the total AER, particularly at older than 40 years."

Raoul C. Reulen, Ph.D., of the University of Birmingham, Edgbaston, United Kingdom, and colleagues conducted a study to investigate the long-term risks of subsequent primary neoplasms in survivors of childhood cancer. The British Childhood Cancer Survivor Study included 17,981 5-year survivors of childhood cancer diagnosed with cancer at younger than 15 years between 1940 and 1991 in Great Britain, who were followed up through December 2006.

Through the follow-up period, 1,354 subsequent primary neoplasms were diagnosed in 1,222 of the 17,981 survivors in the cohort. The average follow-up time from childhood cancer diagnosis was 25.6 years. The most commonly observed subsequent primary neoplasms were central nervous system tumors (n = 344) of which 105 were gliomas, nonmelanoma skin cancer (n = 278), digestive (n = 105), genitourinary (n = 100), breast (n = 97), and bone (n = 94). Overall, survivors were 4 times more likely to develop a subsequent primary neoplasm than expected. Digestive and genitourinary subsequent primary neoplasms contributed the largest AER at older than 40 years compared with other subsequent primary neoplasm categories; 36 percent of the total AER was attributable to genitourinary and digestive subsequent primary neoplasms. Overall, 52 percent of the total AER was attributable to digestive, genitourinary, breast, or respiratory sites at older than 40 years.

"These increased risks of digestive subsequent primary neoplasms are likely to be related to previous exposure of the digestive tract to radiation, except following heritable retinoblastoma. We found a 3-fold increased RR for survivors treated with direct abdomino-pelvic irradiation. The highest AER for genitourinary subsequent primary neoplasms was observed after heritable retinoblastoma, suggesting that this excess risk is at least partially attributable to genetic predisposition," the authors write.

The cumulative percentage of survivors developing a subsequent primary neoplasm increased steadily with attained age from 1.6 percent at age 20 years to 13.8 percent at age 60 years, whereas 8.4 percent was expected at the latter age based on rates from the general population. Five percent of survivors had developed a subsequent primary neoplasm by age 38 years, whereas it took until age 54 years for 5 percent of a comparable cohort (based on the general population rates) to develop a cancer.

The researchers also found that the cumulative incidence of developing colorectal cancer by age 50 years was 1.4 percent for survivors treated with direct abdomino-pelvic irradiation. This risk is comparable to the equivalent percentage (1.2 percent) for individuals with at least 2 first-degree relatives affected by colorectal cancer. They add that this is, to their knowledge, the first time this finding has been demonstrated. "This raises the question of whether childhood cancer survivors treated with direct abdomino-pelvic irradiation should be similarly considered for routine colonoscopy for colorectal cancer."

The authors note that it should be emphasized that the AER for most subsequent primary neoplasms was still relatively low; although for genitourinary and digestive subsequent primary neoplasms, it increased rapidly with attained age, and if continued into old age, a substantial number of survivors would develop such subsequent primary neoplasms. "Given the excesses observed among those older than 40 years, these survivors should be encouraged to participate in existing general population screening programs."


'/>"/>

Contact: Raoul C. Reulen, Ph.D.
r.c.reulen@bham.ac.uk
JAMA and Archives Journals
Source:Eurekalert

Related medicine news :

1. Childhood Cancer Therapies Tied to Gastrointestinal Issues
2. Capacity for Commitment May Start in Early Childhood
3. Experts Say Cholesterol Screenings Should Start in Childhood
4. Childhood cancer survivors at higher risk for future GI complications
5. Sun protects against childhood asthma
6. Cockroach allergens in homes associated with prevalence of childhood asthma in some neighborhoods
7. Cole Foundation injects $700,000 into childhood cancer research
8. Bleak memories of childhood
9. Childhood cancer survivors are at increased risk for ongoing post-therapy GI complications
10. Biological links found between childhood abuse and adolescent depression
11. Childhood music lessons may provide lifelong boost in brain functioning
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/20/2017)... ... 19, 2017 , ... Adolfson & Peterson Construction (AP) continues ... As a leader in healthcare construction, AP has successfully built several well-known medical ... Midwest with Josh now on board. , Josh brings over nine years ...
(Date:7/18/2017)... ... July 18, 2017 , ... CannaKids, a California Cooperative Cooperation that specializes in ... at the WORLDZ Summit, taking place in Hollywood from July 31-August 1, the ... medical cannabis for both pediatric and adult patients, and how the path has led ...
(Date:7/18/2017)... ... ... An inventor from Anacortes, Wash., knows the difficulties and indignity of not being ... I suffer from anxiety and vertigo on top of that," she said, "so I ... meets that need. , This device enables a woman in menopause to cool off ...
(Date:7/17/2017)... , ... July 17, 2017 , ... ... Depression and Its Treatments during Pregnancy , studies take a closer look at ... on a developing baby with one study showing newer medications may be safer ...
(Date:7/17/2017)... (PRWEB) , ... July 17, 2017 , ... ... medical education events, today announced a partnership with the Texas Academy of ... meeting will take place October 20-22, 2017 at the Hyatt Regency Dallas in ...
Breaking Medicine News(10 mins):
(Date:7/13/2017)... Products, a leader in medical product innovation and global patient care, ... hospice patient care. ... Centurion Medical Products ... management and emotional comfort are part of a hospice,s primary mission. ... unneeded emergency department admission due to severe fecal impaction. One of ...
(Date:7/11/2017)... Calif. , July 11, 2017 Zymo Research Corp., also ... service that can quantify biological aging in a precise manner using the ... Steve Horvath , a professor of human genetics and biostatistics at ... Fielding School of Public Health , Zymo Research,s proprietary DNAge ™ ... ...
(Date:7/11/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ... on the development of oral drug delivery systems, announced ... has agreed to schedule an End-of-Phase II meeting with ... its oral insulin capsule ORMD-0801 in the treatment of ... and secondary endpoints by indicating a statistically significant lowering ...
Breaking Medicine Technology: